Kamada Ltd. have announced that favorable results from a preclinical study analyzing the effects of the Company’s human Alpha-1 Antitrypsin (AAT), Glassia, in inter-species islet graft transplantation were published in PLOS One
Read more
JDRF Funded Study Demonstrating Pancreatic Islet Xenograft Survival With Kamada’s AAT
Posted in Artificial Pancreas